BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36107429)

  • 1. Effect of Digital Medication Event Reminder and Monitor-Observed Therapy vs Standard Directly Observed Therapy on Health-Related Quality of Life and Catastrophic Costs in Patients With Tuberculosis: A Secondary Analysis of a Randomized Clinical Trial.
    Manyazewal T; Woldeamanuel Y; Fekadu A; Holland DP; Marconi VC
    JAMA Netw Open; 2022 Sep; 5(9):e2230509. PubMed ID: 36107429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a digital medication event reminder and monitor device for patients with tuberculosis (SELFTB): a multicenter randomized controlled trial.
    Manyazewal T; Woldeamanuel Y; Holland DP; Fekadu A; Marconi VC
    BMC Med; 2022 Sep; 20(1):310. PubMed ID: 36167528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.
    Manyazewal T; Woldeamanuel Y; Holland DP; Fekadu A; Blumberg HM; Marconi VC
    Trials; 2020 May; 21(1):383. PubMed ID: 32370774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported usability and satisfaction with electronic medication event reminder and monitor device for tuberculosis: a multicentre, randomised controlled trial.
    Manyazewal T; Woldeamanuel Y; Getinet T; Hoover A; Bobosha K; Fuad O; Getahun B; Fekadu A; Holland DP; Marconi VC
    EClinicalMedicine; 2023 Feb; 56():101820. PubMed ID: 36684395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial.
    Browne SH; Umlauf A; Tucker AJ; Low J; Moser K; Gonzalez Garcia J; Peloquin CA; Blaschke T; Vaida F; Benson CA
    PLoS Med; 2019 Oct; 16(10):e1002891. PubMed ID: 31584944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis care strategies and their economic consequences for patients: the missing link to end tuberculosis.
    Getahun B; Wubie M; Dejenu G; Manyazewal T
    Infect Dis Poverty; 2016 Nov; 5(1):93. PubMed ID: 27799063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer-aided X-ray screening for tuberculosis and HIV testing among adults with cough in Malawi (the PROSPECT study): A randomised trial and cost-effectiveness analysis.
    MacPherson P; Webb EL; Kamchedzera W; Joekes E; Mjoli G; Lalloo DG; Divala TH; Choko AT; Burke RM; Maheswaran H; Pai M; Squire SB; Nliwasa M; Corbett EL
    PLoS Med; 2021 Sep; 18(9):e1003752. PubMed ID: 34499665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using a Mobile Health Intervention (DOT Selfie) With Transfer of Social Bundle Incentives to Increase Treatment Adherence in Tuberculosis Patients in Uganda: Protocol for a Randomized Controlled Trial.
    Sekandi JN; Onuoha NA; Buregyeya E; Zalwango S; Kaggwa PE; Nakkonde D; Kakaire R; Atuyambe L; Whalen CC; Dobbin KK
    JMIR Res Protoc; 2021 Jan; 10(1):e18029. PubMed ID: 32990629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Financial burden of tuberculosis diagnosis and treatment for patients in Ethiopia: a systematic review and meta-analysis.
    Assefa DG; Dememew ZG; Zeleke ED; Manyazewal T; Bedru A
    BMC Public Health; 2024 Jan; 24(1):260. PubMed ID: 38254019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of an Individually Tailored and Home-Based Intervention in the Chronic Phase of Traumatic Brain Injury: A Randomized Clinical Trial.
    Borgen IMH; Løvstad M; Hauger SL; Forslund MV; Kleffelgård I; Andelic N; Sveen U; Søberg HL; Sigurdardottir S; Winter L; Lindstad MØ; Brunborg C; Røe C
    JAMA Netw Open; 2023 May; 6(5):e2310821. PubMed ID: 37145600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-Person vs Electronic Directly Observed Therapy for Tuberculosis Treatment Adherence: A Randomized Noninferiority Trial.
    Burzynski J; Mangan JM; Lam CK; Macaraig M; Salerno MM; deCastro BR; Goswami ND; Lin CY; Schluger NW; Vernon A;
    JAMA Netw Open; 2022 Jan; 5(1):e2144210. PubMed ID: 35050357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial.
    Liu X; Lewis JJ; Zhang H; Lu W; Zhang S; Zheng G; Bai L; Li J; Li X; Chen H; Liu M; Chen R; Chi J; Lu J; Huan S; Cheng S; Wang L; Jiang S; Chin DP; Fielding KL
    PLoS Med; 2015 Sep; 12(9):e1001876. PubMed ID: 26372470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directly observed therapy for treating tuberculosis.
    Karumbi J; Garner P
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD003343. PubMed ID: 26022367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-utility of cytisine for smoking cessation over and above behavioural support in people with newly diagnosed pulmonary tuberculosis: an economic evaluation of a multicentre randomised controlled trial.
    Li J; Parrott S; Keding A; Dogar O; Gabe R; Marshall AM; Huque R; Barua D; Fatima R; Khan A; Zahid R; Mansoor S; Kotz D; Boeckmann M; Elsey H; Kralikova E; Readshaw A; Sheikh A; Siddiqi K;
    BMJ Open; 2022 Aug; 12(8):e049644. PubMed ID: 36028279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs incurred by patients with drug-susceptible pulmonary tuberculosis in semi-urban and rural settings of Western India.
    Rupani MP; Cattamanchi A; Shete PB; Vollmer WM; Basu S; Dave JD
    Infect Dis Poverty; 2020 Oct; 9(1):144. PubMed ID: 33076969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Tuberculosis With Household Catastrophic Expenditure in South India.
    Muniyandi M; Thomas BE; Karikalan N; Kannan T; Rajendran K; Saravanan B; Vohra V; Okorosobo T; Lönnroth K; Tripathy SP
    JAMA Netw Open; 2020 Feb; 3(2):e1920973. PubMed ID: 32049293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
    Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.